- Home
- NXT vs HALO Comparison
NXT vs HALO Comparison
Compare NXT & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXT
- HALO
- Stock Information
- Founded
- NXT 2013
- HALO 1998
- Country
- NXT United States
- HALO United States
- Employees
- NXT N/A
- HALO N/A
- Industry
- NXT Semiconductors
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NXT Technology
- HALO Health Care
- Exchange
- NXT Nasdaq
- HALO Nasdaq
- Market Cap
- NXT 7.2B
- HALO 7.4B
- IPO Year
- NXT 2023
- HALO N/A
- Fundamental
- Price
- NXT $45.16
- HALO $61.06
- Analyst Decision
- NXT Strong Buy
- HALO Buy
- Analyst Count
- NXT 20
- HALO 9
- Target Price
- NXT $56.00
- HALO $61.63
- AVG Volume (30 Days)
- NXT 2.2M
- HALO 1.4M
- Earning Date
- NXT 01-28-2025
- HALO 05-06-2025
- Dividend Yield
- NXT N/A
- HALO N/A
- EPS Growth
- NXT 111.73
- HALO 63.33
- EPS
- NXT 3.48
- HALO 3.43
- Revenue
- NXT $2,771,370,000.00
- HALO $1,015,324,000.00
- Revenue This Year
- NXT $15.81
- HALO $20.06
- Revenue Next Year
- NXT $11.33
- HALO $23.87
- P/E Ratio
- NXT $12.95
- HALO $17.78
- Revenue Growth
- NXT 21.46
- HALO 22.44
- 52 Week Low
- NXT $30.93
- HALO $37.73
- 52 Week High
- NXT $62.31
- HALO $65.53
- Technical
- Relative Strength Index (RSI)
- NXT 52.61
- HALO 68.07
- Support Level
- NXT $40.21
- HALO $60.38
- Resistance Level
- NXT $45.66
- HALO $63.11
- Average True Range (ATR)
- NXT 2.18
- HALO 1.73
- MACD
- NXT -0.15
- HALO 0.12
- Stochastic Oscillator
- NXT 60.15
- HALO 66.99
About NXT Nextracker Inc.
Nextracker (and its subsidiaries) is a leading provider of intelligent, integrated solar tracker and software solutions used in utility-scale and distributed generation solar projects around the world. Nextracker's products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance. Nextracker has operations in the United States, Mexico, Spain and other countries in Europe, India, Australia, the Middle East, Africa, and Brazil.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.